About IAMRegen

Take Action to regenerate — not replace by default.

IAMRegen is a pan-European Action uniting clinicians, scientists, engineers, industry and patients to put rigorous, evidence-based science back at the centre of musculoskeletal regeneration — turning a fragmented, over-claimed field into a coordinated, standard-setting community. It is the network behind our proposed COST Action for MSK regeneration and joint preservation.

TAKE ACTION FOR REGENERATION  ·  INTERNATIONAL ASSOCIATION OF MUSCULOSKELETAL REGENERATION  ·  PRESERVE · REPAIR · REGENERATE  ·  TAKE ACTION FOR REGENERATION  ·  INTERNATIONAL ASSOCIATION OF MUSCULOSKELETAL REGENERATION  ·  PRESERVE · REPAIR · REGENERATE  ·  
The challenge

1.7 billion people. One coordination failure.

Musculoskeletal conditions are the single largest contributor to disability worldwide — roughly one in six of all years lived with disability. The burden falls hardest on less research-intensive regions of Europe, many of them COST Inclusiveness Target Countries that carry the highest rates while remaining least connected to the field’s emerging science.

A new generation of regenerative therapies is advancing fast — but the field is fragmented and inconsistently defined, with no shared classification, no agreed outcome standard, no European quality benchmark and no coordinated training route. Evidence cannot be pooled, effort is duplicated, and unproven treatments compete on equal footing with evidence-based ones. This is a coordination failure no single research project can solve.

1.7B
People affected by MSK conditions worldwide
~600M
Living with osteoarthritis
#1
Cause of disability in 160 countries (low back pain)
+75%
Projected rise in knee OA by 2050
The scientific premise

Preserve. Repair. Regenerate. Before replace.

Repair and regeneration are points on the same biological continuum: repair restores the integrity of injured tissue; regeneration restores its structure and function. The body does both remarkably well — a marathon runner’s calf recovers in 24–48 hours — but when degeneration outpaces healing, replacement becomes the default. IAMRegen’s ambition is to shift the balance of care up the pathway, so stimulating the body’s own capacity reduces the need to replace the joint.

01
Preserve
Protect joint and tissue integrity before damage outpaces healing.
02
Repair
Restore the integrity of injured tissue through the body’s own healing.
03
Regenerate
Restore original structure and function — stimulate and sustain regeneration.
04
Replace
Surgical replacement — effective, but the last resort, not the default.
Our framework · RCO1

SPIRO — a shared language for the field.

SPIRO classifies regenerative and orthobiologic MSK therapies across five domains, mapped to the Preserve → Repair → Regenerate → Replace pathway. It is developed and ratified by a structured, modified two-round Delphi consensus with an a priori agreement threshold — removing the field’s core definitional fragmentation.

S
Structural
Does the therapy restore tissue architecture and load-bearing structure?
P
Permanent
Is the effect durable, or transient symptom relief?
I
Injectable
Delivery route — injectable, implanted or surgical.
R
Regenerative
True regeneration of tissue versus repair or replacement.
O
Origin
Source of the biologic — autologous, allogeneic, cell, plasma or synthetic.
Aligned to COST · our objectives

Eight objectives. Two engines.

Research Coordination
RCO1Shared classification & language
Ratify the SPIRO framework and clinical pathway by structured two-round Delphi consensus — an open-access statement and terminology lexicon.
RCO2Outcome & reporting standards
Agree a minimum core outcome set and harmonised reporting so results are comparable across centres and countries.
RCO3Map & synthesise the evidence
Map European centres, capabilities and evidence gaps into a shared research agenda that avoids duplication.
RCO4Quality standards for care
Define transparent, non-commercial criteria for a quality regenerative centre — the Centre of Excellence framework.
Capacity Building
CBO1Critical mass across the value chain
Convene clinicians, scientists, biomaterials engineers, industry, regulators and patients in one balanced community.
CBO2Train the next generation
Training Schools and Short-Term Scientific Missions that give early-career researchers skills, mobility and real leadership.
CBO3Patient & public involvement
Involve patients in setting the agenda and separate evidence-based regeneration from commercial hype.
CBO4A durable European home
A self-sustaining society that continues the coordination and briefs regulators beyond the funded Action.
Why a COST Action

The barrier is coordination, not discovery.

The knowledge, techniques and expert groups already exist across Europe. What is missing is a shared framework, comparable evidence, agreed standards and a route for people and knowledge to move between centres — networking problems by definition. A pan-European COST Action funds exactly this: consensus, common standards, training, mobility and dissemination.

COST funds the networking, not the research — so partners join and benefit at no research cost to their institution. The consortium is built to COST eligibility: at least seven COST Full or Cooperating Members, at least half from Inclusiveness Target Countries, and at least 40% Young Researchers and Innovators.

Working Groups
Consensus, standards, evidence, training and inclusiveness.
Training Schools
Structured, geographically inclusive skills transfer.
STSMs
Short-Term Scientific Missions move people between centres.
Dissemination
Open outputs, congress and public engagement.
Become a founding partner.
Research groups, clinicians, SMEs and patient organisations across the COST Member Countries are warmly invited. e-COST opens 31 July 2026; collection deadline 28 October 2026.
[email protected]
What the network delivers
MISSION
Advance regeneration
Accelerate evidence-based musculoskeletal regeneration — biologics, cell therapy, tissue engineering and rehab — across borders.
METHOD
Build consensus
Replace fragmented opinion with a structured, annual international consensus the whole field can cite and trust.
CULTURE
Recognise people
Make membership something you earn and announce — a status system that rewards real contribution, not seniority.
COMMUNITY
A global MDT community
Connect an international multidisciplinary community — surgeons, scientists, engineers and physios discussing real cases together, so no one decides alone.
EXPERTISE
Local champions
No one is good at everything all the time. The network names a subject-matter champion for each regenerative treatment — so as new therapies emerge, someone is always expert, and the network is always current.
INCLUSION
Science meets clinic
An inclusive culture that mixes scientists and clinicians across borders and career stages — bench and bedside in the same room, so discovery and practice move together.
Our history

Five meetings, one growing Action.

From a founding meeting at the Royal Society of Medicine to an international association — Torino 2027 is our fifth annual meeting.

'27
5th Meeting
Accademia di Medicina, Torino
The fifth meeting in the continuing series and the first held under the IAMRegen name — membership ceremony, expanded programme and the official publishing partnership with ORTST.
'26
4th Meeting
Hacettepe University, Ankara, Türkiye
The masterclass programme developed. In June 2026 the founders formally established IAMRegen at an executive meeting in Berlin.
'25
3rd Meeting
London
Returning to London — membership and the Delphi consensus method took shape.
'24
2nd Meeting
Antalya, Türkiye
The meeting series went international in Antalya, alongside the 33rd National Turkish Orthopaedics Congress.
'23
1st Meeting
London
The first MSK Regen Conference — the start of the continuing international meeting series.
Founding officers & governance
Our crest

The seal of the International Association of Musculoskeletal Regeneration.

Our official crest gathers the story of I AM Regen into a single emblem — myth, science and medicine held together. Every figure carries meaning.

Official crest of the International Association of Musculoskeletal Regeneration (I AM Regen) — an angel carrying the next generation, flanked by a phoenix and a unicorn, beneath an open book, DNA and molecular science, standing on orthopaedics and mitochondria, with the Latin motto Artis Curandi Renovatio.
The angel with the olive branch
Carrying the next generation and holding the light for the future — peace, hope and the duty of care passed from one generation of healers to the next.
The phoenix
The power of renewal and rebirth — tissue and the field itself rising again, regenerated rather than replaced.
The unicorn
The ancient symbol of healing — purity and the restorative power at the heart of regenerative medicine.
The open book, DNA & molecules
Knowledge and the science of regeneration — holding the future of molecular science, genetics and evidence-based practice.
The ground of orthopaedics & mitochondria
Rooted in the musculoskeletal system and cellular energy — the biological foundation the whole movement stands on.
The R. & "I AM Regen"
Our mark at the centre of the seal — the declaration every member and fellow carries.
The motto
Artis Curandi Renovatio
Scientia et Humanitate.

“Renewing the art of healing through science and humanity.” — the guiding principle of the International Association of Musculoskeletal Regeneration.

Frequently asked questions

About I AM Regen.

What is I AM Regen?

I AM Regen is the International Association of Musculoskeletal Regeneration — an international professional programme operated by MSK REGEN (registered charity no. 1211400, England and Wales). It is professionally informed and trustee-governed, and brings clinicians, scientists and centres together to develop transparent standards, consensus and education for musculoskeletal regeneration.

Read more about I AM Regen
Who leads the International Association of Musculoskeletal Regeneration?

I AM Regen is a programme of the charity MSK REGEN; its trustees hold ultimate governance. The programme is led by an executive team: a President (Professor Paul Lee), a President-Elect who also chairs the Scientific Advisory Board (Professor Feza Korkusuz), a Vice-President (Professor Luminita Labusca), a Congress President and Education Vice-President (Professor Riccardo Ferracini) and a Research & Grants Vice-President who co-chairs the Scientific Advisory Board (Professor Victoria Sarafian). These are programme appointments; Members and Fellows do not have a governance vote.

Meet the executive team
What is the difference between an I AM Regen Member and a Fellow?

Members join the programme by application. Fellow is a recognition of standing and contribution, by application and invitation — the honour is not purchasable. Fellows can host visiting fellowships and lead I AM Regen Centres of Excellence. Member membership is €100/year and includes Congress registration, subject to capacity and event rules; the Fellow service tier is €150/year.

Compare Member & Fellow
How do I join I AM Regen?

Apply and pay online as a Member for €100/year (Student €50/year with current-enrolment evidence). Membership includes Congress registration, subject to capacity and event rules, and makes you eligible to take part in the consensus process. Membership does not buy authorship or a governance vote.

Join I AM Regen
What is an I AM Regen Centre of Excellence?

An I AM Regen Centre of Excellence is a clinic or laboratory recognised by IAMRegen under a published standard for regenerative practice or science. Recognition is voluntary and time-limited — it is not a licence to practise, regulatory approval or a certification of every practitioner or treatment.

Explore Centres of Excellence
When and where is the next I AM Regen Congress?

The 5th IAMRegen International Congress takes place on Friday 12 February 2027 at the Accademia di Medicina in Torino, Italy, in person only. It is the fifth meeting in the continuing MSK Regen–IAMRegen series and the first held under the IAMRegen name.

See the Torino 2027 Congress
What is the I AM Regen consensus (Delphi) process?

IAMRegen develops consensus through two anonymous online Delphi rounds with published thresholds, ratified at the in-person Congress. The first IAMRegen consensus programme is in development and no annual consensus has yet been published. Completing both rounds and attending the Congress qualifies a participant for collaborator recognition — authorship is separate and contribution-based.

About the consensus process
What is the I AM Regen Travelling Fellowship?

The I AM Regen Travelling Fellowship connects the network lab to lab and clinic to clinic: a Fellow hosts at their I AM Regen Centre of Excellence and Members apply to visit, learn and collaborate.

About the Travelling Fellowship